Home > Education Hub > Alira Health Advises Trill Impact Entering a Strategic Alliance with TT medic

Alira Health Advises Trill Impact Entering a Strategic Alliance with TT medic

We are pleased to have been a Commercial Due Diligence advisor for Trill Impact, a pioneering Impact House with around EUR 1.2 billion in assets under management, joining forces with TT medic GmbH, a medtech development and manufacturing partner for high-quality polymer components operating in Austria, Switzerland and Germany.

News

Category:

Published on:

April 29, 2024

It was a pleasure to advise the Trill team leading to this exciting partnership. TT medic is a high-quality contract manufacturer in selected critical medtech segments with attractive growth opportunities ahead.”

Dr. Michal Raciborski Managing Partner, Financial Sponsors

TT medic has established itself as a recognized player in the field of medtech, with a focus on precision medical injection molding, operating as a contract development and manufacturing organization (CDMO). The company covers almost the entire value chain, allowing to position itself as a fully integrated partner for medtech OEMs, and the customer base includes global, industry-leading medtech OEMs with whom TT medic has maintained long-term relationships.

For more information on the partnership, read the press release on the Trill Impact Website. To learn more about Alira Health’s commercial due diligence services, and other consulting and clinical services enabled by technology and real-world evidence, visit AliraHealth.com.